Clinical trials

5

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Efficacy and Safety of Bailout Intracranial Angioplasty or Stenting After Thrombectomy for Acute Intracranial Atherosclerotic Large Vessel Occlusion (ANGEL-REBOOT 2)

A multicenter, randomized, open-label, blinded-endpoint trial with a concurrent prospective observational cohort to compare bailout intracranial angioplasty or stenting versus standard therapy on functional outcome, stroke recurrence, and mortality in patients with acute intracranial atherosclerotic stenosis-related large vessel occlusion after thrombectomy.

Participants needed: 420
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Feng GaoUpdated: Jun 1, 2026Locations: 1
Eligibility criteria

Age≥18 years. [+9]

Any sign of intracranial hemorrhage (ICH, except microbleeds) on baseline brain... [+16]

Status: Not yet recruiting

Randomized Clinical Trial of Endovascular Treatment for Progressive Stroke With Vertebrobasilar Artery Occlusion

This multicenter, prospective, open-label randomized controlled trial with blinded assessment was designed to assess the efficacy and safety of endovascular treatment for progressive stroke due to vertebrobasilar artery occlusion.

Participants needed: 240
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Feng GaoUpdated: Apr 29, 2026Locations: 1
Eligibility criteria

Age ≥18 years. [+7]

Any sign of intracranial hemorrhage (except microbleeds) on baseline brain imagi... [+18]

Status: Not yet recruiting

Randomized Clinical Trial of Endovascular Recanalization for Symptomatic Non-Acute Intracranial Artery Occlusion(REPAIR)

A multicenter, randomized, open-label, endpoint-blinded trial to compare the effects of endovascular recanalization plus aggressive medical management with aggressive medical management alone on stroke recurrence and mortality in patients with symptomatic non-acute intracranial artery occlusion.

Participants needed: 286
Trial details
Age: 18-80Biological sex: AllType: InterventionalSponsor: Feng GaoUpdated: Mar 27, 2026Locations: 1
Eligibility criteria

Age ranging between 18 and 80 years. [+9]

Severe stenosis (70%-99%) or occlusion of other arteries, or tandem stenosis (70... [+12]

Status: Not yet recruiting

The Efficacy and Safety of Endovascular Treatment for Acute Mild Basilar Artery Occlusion

This study assesses the efficacy and safety of endovascular treatment for acute mild basilar artery occlusion within a multicenter, prospective, open-label, endpoint-blinded, randomized controlled clinical trial.

Participants needed: 230
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Feng GaoUpdated: Feb 5, 2026Locations: 1
Eligibility criteria

Age≥18 [+6]

Any sign of intracranial hemorrhage (except microbleeds) on brain imaging prior... [+16]

Status: Not yet recruiting

A Response Surface Analysis for the Interaction Between Ciprofol and Sevoflurane

Intravenous and inhalation combined anesthesia is a commonly used method for maintaining general anesthesia in clinical practice. This study aims to explore the interaction between ciprofol and sevoflurane. By employing response surface methodology, we constructed a three-dimensional pharmacodynamic interaction surface for various dose combinations of ciprofol and sevoflurane. This approach allows us to determine the nature of the interaction between the two drugs at any given level, thereby providing a ciprofol understanding of the dose-response relationship when ciprofol and sevoflurane are used in combination. This knowledge will serve as a theoretical basis for rational drug administration during surgery.

Participants needed: 300
Trial details
Phase: Phase 4Age: 18-60Biological sex: AllType: InterventionalSponsor: Feng GaoUpdated: Jan 14, 2025
Eligibility criteria

Patients undergoing elective general anesthesia and non-cardiac surgery; [+3]

Preoperative assessment of potential difficult airway risk; [+7]